Allergy Therapeuti (NASDAQ:AGYTF) has received an average broker rating score of 1.00 (Strong Buy) from the one brokers that cover the company, Zacks Investment Research reports. One investment analyst has rated the stock with a strong buy recommendation.

Zacks has also given Allergy Therapeuti an industry rank of 119 out of 265 based on the ratings given to its competitors.

Separately, Zacks Investment Research raised shares of Allergy Therapeuti from a “sell” rating to a “hold” rating in a report on Monday, September 18th.

Allergy Therapeuti (NASDAQ:AGYTF) remained flat at $$0.43 on Friday.

WARNING: “Allergy Therapeuti (AGYTF) Receives Average Recommendation of “Strong Buy” from Brokerages” was posted by American Banking News and is the property of of American Banking News. If you are reading this story on another publication, it was illegally copied and republished in violation of U.S. and international copyright and trademark laws. The original version of this story can be viewed at https://www.americanbankingnews.com/2017/11/03/allergy-therapeuti-agytf-receives-average-recommendation-of-strong-buy-from-brokerages.html.

Get a free copy of the Zacks research report on Allergy Therapeuti (AGYTF)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Allergy Therapeuti Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allergy Therapeuti and related companies with MarketBeat.com's FREE daily email newsletter.